Lv J et al (2023) Epigenetic landscape reveals MECOM as an endothelial lineage regulator. Nat Commun 14(1):2390
Article PubMed PubMed Central Google Scholar
Lee S et al (2009) Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113(8):1856–1859
Wigle JT et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21(7):1505–1513
Article PubMed PubMed Central Google Scholar
Hong YK et al (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225(3):351–357
Srinivasan RS et al (2010) The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24(7):696–707
Article PubMed PubMed Central Google Scholar
Ma W et al (2021) Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance. Sci Adv 7(18):eabe7359
Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438(7070):946–953
Petrova TV, Koh GY (2020) Biological functions of lymphatic vessels. Science 369(6500):eaax4063
Oliver G, Detmar M (2002) The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7):773–783
Potente M, Makinen T (2017) Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 18(8):477–494
Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17(11):1371–1380
Koch S et al (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169–183
Jeltsch M et al (2013) Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol 5(9):a009183
Article PubMed PubMed Central Google Scholar
Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8(6):464–478
Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669–676
Secker GA, Harvey NL (2021) Regulation of VEGFR signalling in lymphatic vascular development and disease: an update. Int J Mol Sci 22(14):7760
Article PubMed PubMed Central Google Scholar
Karaman S, Leppanen VM, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145(14):dev151019
Karaman S et al (2022) Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance. J Exp Med 219(3):e20210565
Article PubMed PubMed Central Google Scholar
Makinen T et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7(2):199–205
Karkkainen MJ et al (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74–80
Zhang L et al (2010) VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 20(12):1319–1331
Zhang Y et al (2018) Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms. Nat Commun 9(1):1296
Article PubMed PubMed Central Google Scholar
Dixelius J et al (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem 278(42):40973–40979
Deng Y, Zhang X, Simons M (2015) Molecular controls of lymphatic VEGFR3 signaling. Arterioscler Thromb Vasc Biol 35(2):421–429
Nilsson I et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. Embo J 29(8):1377–1388
Article PubMed PubMed Central Google Scholar
Albuquerque RJ et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15(9):1023–1030
Article PubMed PubMed Central Google Scholar
Vogrin AJ et al (2019) Evolutionary differences in the Vegf/Vegfr code reveal organotypic roles for the endothelial cell receptor kdr in developmental lymphangiogenesis. Cell Rep 28(8):2023–2036 e4
Dellinger MT et al (2013) Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS ONE 8(9):e74686
Article PubMed PubMed Central Google Scholar
Nagy JA et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196(11):1497–1506
Article PubMed PubMed Central Google Scholar
Wirzenius M et al (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204(6):1431–1440
Article PubMed PubMed Central Google Scholar
Li X et al (2016) VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread. Nat Commun 7:11017
Article PubMed PubMed Central Google Scholar
Okabe K et al (2014) Neurons limit angiogenesis by titrating VEGF in Retina. Cell 159(3):584–596
Bazigou E et al (2011) Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 121(8):2984–2992
Article PubMed PubMed Central Google Scholar
Kazenwadel J et al (2023) A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature. Nature 614(7947):343–348
Haigh JJ et al (2003) Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 262(2):225–241
Liu Q et al (2015) Genetic targeting of sprouting angiogenesis using Apln-CreER. Nat Commun 6:6020
Article PubMed PubMed Central Google Scholar
Choi I et al (2011) Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117(1):362–365
Comments (0)